Extract
Despite disruptions caused by the coronavirus disease 2019 (COVID-19) pandemic, tuberculosis (TB) is still one of the top causes of death from an infectious disease, killing more than 1.6 million people worldwide every year [1]. TB is curable with prompt detection and appropriate treatment, but it is estimated that over 30% of TB cases go undiagnosed annually [1]. Early diagnosis is crucial for optimal TB outcomes, especially among those most vulnerable to the disease, such as people living with HIV (PLHIV), who experience higher rates of death from TB than those who are HIV negative [1].
Tweetable abstract
This study provides an update on the implementation of lateral flow LAM testing in national guidelines and identifies the major barriers that may be preventing widespread use of the test https://bit.ly/44NfxZ3
Acknowledgements
The authors acknowledge Valerie Donkeng, National Reference Laboratory for Tuberculosis and Buruli Ulcer, Centre Pasteur du Cameroun (CPC), and Melissa Sander, Center for Health Promotion and Research, Cameroon.
Footnotes
Conflict of interest: All authors have no potential conflicts of interest to disclose.
- Received April 11, 2023.
- Accepted July 26, 2023.
- Copyright ©The authors 2023. For reproduction rights and permissions contact permissions{at}ersnet.org
